DK162641B - 4-SUBSTITUTED THIOPHEN-2 (5H) -ON DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF - Google Patents
4-SUBSTITUTED THIOPHEN-2 (5H) -ON DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF Download PDFInfo
- Publication number
- DK162641B DK162641B DK233186A DK233186A DK162641B DK 162641 B DK162641 B DK 162641B DK 233186 A DK233186 A DK 233186A DK 233186 A DK233186 A DK 233186A DK 162641 B DK162641 B DK 162641B
- Authority
- DK
- Denmark
- Prior art keywords
- formula
- process according
- chloro
- acid
- thiophen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Abstract
Description
iin
DK 162641 BDK 162641 B
Opfindelsen angår hidtil ukendte 4-substituerede thiophen-2(5H)-on-derivater med den nedenfor anførte formel I, som let kan omdannes til thiotetronsyre, samt en fremgangsmåde 5 til fremstilling af de 4-substituerede thiophen-2(5H)-on-derivater.The invention relates to novel 4-substituted thiophen-2 (5H) -one derivatives of formula I which can be readily converted to thiotetronic acid and a process 5 for the preparation of the 4-substituted thiophen-2 (5H) -one derivatives.
Thiotetronsyre selv har betydelige potentielle anvendelsesmuligheder som mellemprodukt til fremstillingen af (±Jthiolactomycin, som er et bredsprektret antibiotikum, 10 jf. Tetrahedron Letters, bind 25, nr. 46, side 5243-5246, 1984. Det er kendt at fremstille thiotetronsyre ud fra acetyltioglycoylchlorid ved omsætning med natriummalon-ester og efterfølgende ringslutning og behandling med vand, jf. E. Benary, Chem. Berichte 46, 2103 (1913). Denne 15 reaktion er blevet videreudviklet således, at thiotetronsyre kan fremstilles i et udbytte på 30,3%, beregnet på det anvendte acetylthioglycoylchlorid, jf, D.B. Maciere-wicz, Rocz. Chem. 47, 1735 (1973). Det er endvidere kendt at fremstille thiotetronsyre i et udbytte på 46,2% ud fra 20 2,4-dibromthiophen ved omsætning over 3 trin med butyl-lithium og t-butylperbenzoat, jf. J.Z. Mortensen et al, Tetrahedron 27, 3839 (1971).Thiotetronic acid itself has significant potential uses as an intermediate for the preparation of (± Jthiolactomycin, which is a broad-spectrum antibiotic, cf. Tetrahedron Letters, Vol. by reaction with sodium malon ester and subsequent cyclization and treatment with water, cf. E. Benary, Chem. Berichte 46, 2103 (1913) .This reaction has been further developed such that thiotetronic acid can be prepared in a yield of 30.3%. , calculated on the acetylthioglycoyl chloride used, cf. DB Macierewicz, Rocz, Chem. 47, 1735 (1973). Further, it is known to produce thiotetronic acid in 46.2% yield from 2,4-dibromothiophene by reaction. over 3 steps with butyl lithium and t-butyl perbenzoate, cf. JZ Mortensen et al, Tetrahedron 27, 3839 (1971).
Ved disse kendte fremgangsmåder er ikke alene udbytterne for små, men også de anvendte udgangsmaterialer og 25 reagenser stiller sig hindrende i vejen for en økonomisk teknisk fremgangsmåde.In these known processes, not only are the yields too small, but also the starting materials used and reagents used are hindering the way of an economical technical process.
Et andet problem består i fremstillingen af et kvalitativt værdifuldt produkt, da thiotetronsyre såvel ved omkrystallisation som i vandige opløsninger danner et 30 dimert kondensationsprodukt under vandfraspaltning.Another problem consists in the preparation of a qualitatively valuable product, since thiotetronic acid forms, both in recrystallization and in aqueous solutions, a 30 dimer condensation product during water decomposition.
Det er formålet med den foreliggende opfindelse at tilvejebringe et alternativt mellemprodukt for thiotetronsyre, hvilket mellemprodukt kan fremstilles teknisk på enkel måde, isoleres fra reaktionsblandingen iIt is the object of the present invention to provide an alternative intermediate for thiotetronic acid, which intermediate can be prepared technically in a simple manner, isolated from the reaction mixture in
DK 162641 BDK 162641 B
2 høj renhed og omdannes til thiotetronsyre på enkel måde.2 high purity and converted to thiotetronic acid in a simple manner.
Dette opnås med de hidtil ukendte 4-substituerede thiophen-2(5H)-on-dérivater ifølge opfindelsen, som er 5 ejendommelige ved, at de har den almene formel ROv._ \ J=° 1 hvori R betyder en C(l-8)-alkoxycarbonylgruppe, en benzyloxycarbonylgruppe eller en p-toluensulfonylgrupe.This is achieved with the novel 4-substituted thiophene-2 (5H) -one derivatives of the invention, which are peculiar in that they have the general formula ROv._ \ J = ° 1 wherein R is a C (1- 8) -alkoxycarbonyl group, a benzyloxycarbonyl group or a p-toluenesulfonyl group.
Fremgangsmåden ifølge opfindelsen til fremstilling af de 10 4-substituerede thiophen-2(5H)-on-derivater raed den almene formel I er ejendommelig ved, at 4-chlor-4-chlormethyl-oxetan-2-on med formlenThe process of the invention for the preparation of the 4-substituted thiophen-2 (5H) -one derivatives of general formula I is characterized in that 4-chloro-4-chloromethyl-oxetan-2-one of the formula
Hv-HHV-H
Cl /XCl / X
/ c\ /c=0 H2CC1 X0x omsættes med dihydrogensulfid i nærværelse af en base, og 15 den intermediært dannede thiotetronsyre med formlen HO______ \ ^J=° omsættes med en chlormyresyreester med formlen C1C00R, hvor R har den ovenfor angivne betydning eller medis reacted with dihydrogen sulfide in the presence of a base, and the intermediately formed thiotetronic acid of formula HO______ \ J = ° is reacted with a chloroformic acid ester of formula C1C00R wherein R is as defined above or by
DK 162641 BDK 162641 B
3 p-toluensulfonsyrechlorid.3 p-toluenesulfonic acid chloride.
4-Chlor-4-chlormethyloxetan~2-on kan fremstilles på enkel måde, jf. beskrivelsen til europæisk patentansøgning nr.4-Chloro-4-chloromethyloxetane ~ 2-one can be prepared in a simple manner, as described in European patent application no.
5 60.808, og kan efter en flashdestillation anvendes ved den omhandlede omsætning.No. 5,60,808, and can be used in the instant reaction after a flash distillation.
Dihydrogensulfidet anvendes hensigtsmæssigt på gasform.The dihydrogen sulfide is suitably used in gaseous form.
Som eksempler på egnede baser kan nævnes primære, sekundære eller tertiære aminer, ammoniak eller guanidin.Examples of suitable bases include primary, secondary or tertiary amines, ammonia or guanidine.
10 Særligt fordelagtige aminer er de tertiære aminer, f.eks. triethylamin. Hensigtsmæssigt anvendes chlormyresyre-C(1-8)-alkyl- eller -benzylester. Til fremstilling af foretrukne thiophenonderivater anvendes chlormyresyre-C(1-2)-alkylestrene.Particularly advantageous amines are the tertiary amines, e.g. triethylamine. Chloric formic acid C (1-8) alkyl or benzyl ester is suitably used. For the preparation of preferred thiophenone derivatives, the chloroformic acid C (1-2) alkyl esters are used.
15 Det er endvidere hensigtsmæssigt at genemføre omsætningen i opløsningsmidler. Der kan anvendes opløsningsmidler, som er indifferente over for det anvendte udgangsmateriale, såsom halogenerede carbonhydrider, ethere eller carboxyl-syreestere. Som eksempler på anvendelige opløsningsmidler 20 kan nævnes methylenchlorid, chloroform og etheropløs-ningsmidler, såsom tetrahydrofuran. Det foretrækkes især at anvende tetrahydrofuran eller ethylacetat.Furthermore, it is appropriate to carry out the reaction in solvents. Solvents which are inert to the starting material used, such as halogenated hydrocarbons, ethers or carboxylic acid esters, may be used. As examples of useful solvents 20 may be mentioned methylene chloride, chloroform and ether solvents such as tetrahydrofuran. It is particularly preferred to use tetrahydrofuran or ethyl acetate.
Udgangsmaterialerne anvendes hensigtsmæssigt i molforholdet 4-chlor-4-chlormethyloxetan-2-on til dihydrogensulfid 25 til base til chlormyresyreester/p-toluensulfonsyrechlorid på 1:1:2,8:0,8 til 1:3:4:1, fortrinsvis fra 1:2:2,8:0,8 til 1:3:3,0:1.The starting materials are suitably used in the molar ratio of 4-chloro-4-chloromethyloxetan-2-one to dihydrogen sulfide 25 to base for chloroformic acid ester / p-toluenesulfonic acid chloride of 1: 1: 2.8: 0.8 to 1: 3: 4: 1, preferably from 1: 2: 2.8: 0.8 to 1: 3: 3.0: 1.
Det foretrækkes at arbejde ved temperaturer fra -40°C til 20°C, specielt mellem -20eC og -10eC.It is preferred to operate at temperatures from -40 ° C to 20 ° C, especially between -20 ° C and -10 ° C.
30 Ved en hensigtsmæssig udførelsesform for fremgangsmådenIn an appropriate embodiment of the method
DK 162641 BDK 162641 B
4 sættes en opløsning af 4-chlor-4-chlormethyloxetan-2-on i et indifferent opløsningsmiddel med dihydrogensu1f id, hvorefter basen tilsættes i løbet af 30-120 minutter.4, a solution of 4-chloro-4-chloromethyloxetan-2-one is added in an inert solvent with dihydrogen sulfide and the base is added over 30-120 minutes.
5 Efter amintiIsætningen kan den intermediært dannede thiotetronsyre uden isolering omsættes direkte i opløsning med chlormyresyreester eller p-toluensulfonsyrechlorid til thiophenonderivaterne ifølge opfindelsen.After the amine addition, the intermediate thiotetronic acid formed without isolation can be reacted directly in solution with chloroformic acid ester or p-toluenesulfonic acid chloride to the thiophenone derivatives of the invention.
Isoleringen af thiophenonderivaterne med formlen I kan 10 gennemføres på enkel måde ved ekstraktion eller ved omkrystallisation. Der kan på denne måde opnås udbytter på mere end 70% i en renhed på mindst 90%, i visse tilfælde på mere end 99%.The isolation of the thiophenone derivatives of formula I can be accomplished simply by extraction or by recrystallization. In this way, yields of more than 70% can be obtained in a purity of at least 90%, in some cases more than 99%.
Omsætningen af thiophenonderivaterne med formlen I til 15 thiotetronsyre gennemføres i basisk miljø, hensigtsmæssigt i nærværelse af en aliphatisk amin eller NH3. Efter hensigtsmæssig oparbejdning kan der fås en kvalitativ værdifuld thiotetronsyre med en renhed på over 95%.The reaction of the thiophenone derivatives of formula I to 15 thiotetronic acid is carried out in a basic environment, conveniently in the presence of an aliphatic amine or NH 3. After proper work-up, a qualitatively valuable thiotetronic acid with a purity greater than 95% can be obtained.
Som særligt foretrukne forbindelser, som i særlig høj grad 20 medfører de ovennævnte fordele, kan nævnes 4-(ethoxy-carbonyloxy)-thiophen-2(5H)-on og 4-(methoxycarbonyloxy)-thiophen-2(5H)-on.Particularly preferred compounds which provide particularly high benefits to the aforementioned advantages may be mentioned 4- (ethoxy-carbonyloxy) -thiophen-2 (5H) -one and 4- (methoxycarbonyloxy) -thiophen-2 (5H) -one.
Opfindelsen illustreres nærmere i de efterfølgende eksempler 1-5. Fremstillingen af thiotetronsyre ud fra et 25 4-substitueret thiophen-2(5H)-on-derivat illustreres i eksempel 6.The invention is further illustrated in the following Examples 1-5. The preparation of thiotetronic acid from a 4-substituted thiophene-2 (5H) -one derivative is illustrated in Example 6.
DK 162641 BDK 162641 B
Eksempel 1 5Example 1 5
En opløsning af 15,9 g (0,1 mol) 4-chlor-4-chlormethyloxetan- 2-on i 300 ml tetrahydrofuran afkøles til -20°C, hvorpå opløsningen mættes med gasformig dihydrogensulfid. Derefter 5 tilsættes dråbevis under kraftig omrøring i løbet af en time 20,4 g (0,2 mol) triethylamin. Reaktionsopløsningen henstår til opvarmning til stuetemperatur, efterrøres i en time, hvorpå det udfældede salt frafiltreres, og opløsningsmidlet afdampes på en rotationsfordamper til det 10 halve rumfang. Til denne opløsning sættes 9,8 g (0,09 mol) chlormyresyreethylester, hvorpå blandingen afkøles til 0°C, og der tilsættes dråbevis 9,1 g (0,09 mol) triethyl-, amin. Det udfældede salt frafiltreres, og reaktionsopløsningen inddampes på en rotationsfordamper. Remanensen ud-15 koges med 400 ml petroleumsether, opløsningen dekanteres og afkøles til -20°C. De udfældede krystaller isoleres ved sugefiltrering. Man får 15,0 g 4-(ethoxycarbonyloxy)-thiophen-2 (5H)-on i form af beigefarvede krystaller med smp. 52-54°C og en renhed på 99,2% (GC). Dette svarer 20 til 14,9 g 100%'s rent produkt eller et udbytte på 79,1%, beregnet på den anvendte oxetanon.A solution of 15.9 g (0.1 mole) of 4-chloro-4-chloromethyloxetan-2-one in 300 ml of tetrahydrofuran is cooled to -20 ° C and the solution is saturated with gaseous dihydrogen sulfide. Thereafter, 20.4 g (0.2 mole) of triethylamine are added dropwise with vigorous stirring over one hour. The reaction solution is allowed to warm to room temperature, stirred for one hour, then the precipitated salt is filtered off and the solvent is evaporated on a rotary evaporator to half the volume. To this solution is added 9.8 g (0.09 mole) of chloroformic acid ethyl ester, then the mixture is cooled to 0 ° C and 9.1 g (0.09 mole) of triethyl, amine are added dropwise. The precipitated salt is filtered off and the reaction solution is evaporated on a rotary evaporator. The residue is boiled with 400 ml of petroleum ether, the solution is decanted and cooled to -20 ° C. The precipitated crystals are isolated by suction filtration. 15.0 g of 4- (ethoxycarbonyloxy) -thiophen-2 (5H) -one are obtained in the form of beige crystals, m.p. 52-54 ° C and a purity of 99.2% (GC). This corresponds to 20 to 14.9 g of 100% pure product or a yield of 79.1%, calculated on the oxetanone used.
1H-NMR-spektrum (CDCI3, 300 MHz) β = 6,42 (t, J3 5 = 1,3 Hz, IH) 4,29 (q, J = 7,1 Hz, 2H) 25 4,02 (d, J3 5 = 1,3 Hz, 2H) 1,33 (t, J = 7,1 Hz, 3H)1 H NMR Spectrum (CDCl 3, 300 MHz) β = 6.42 (t, J 3 = 1.3 Hz, 1H) 4.29 (q, J = 7.1 Hz, 2H) 4.02 (d = 1.3 Hz, 2H) 1.33 (t, J = 7.1 Hz, 3H)
Eksempel 2Example 2
Analogt med den ovenfor i eksempel 1 beskrevne fremgangsmåde, idet man dog i stedet for chlormyresyreethylester 30 anvender 8,50 g (0,09 mol) chlormyresyremethylester, fremstilles 4- (methoxycarbonyloxy)-thiophen-2 (5H)-on i et udbytte på 13,8 g = 79,2%, beregnet på den anvendte oxetanon. Det beigefarvede produkt har et smelteområde på 64-66°C og en renhed bestemt ved gaskromatografi på 92,1%.By analogy to the procedure described in Example 1, however, using 8.50 g (0.09 mol) of chloroformic acid methyl ester instead of chloroformic acid ethyl ester, 4- (methoxycarbonyloxy) -thiophen-2 (5H) -one is prepared in a yield of 13.8 g = 79.2%, based on the oxetanone used. The beige colored product has a melting range of 64-66 ° C and a purity determined by gas chromatography of 92.1%.
DK 162641 BDK 162641 B
6 1H-NMR-spektrum (CDC13, 300 MHz) δ « 6,49 (tf J3 5 = 1,3 Hz, IH) 4,05 (d, J3 = 1,3 Hz, 2H) 3.96 (s, 3H) 5 Eksempel 31 H NMR Spectrum (CDCl3, 300 MHz) δ δ 6.49 (tf J3 = 1.3 Hz, 1H) 4.05 (d, J3 = 1.3 Hz, 2H) 3.96 (s, 3H) Example 3
En opløsning af 16,3 g (0,1 mol) 4-chlor-4-chlormethyl-oxetan-2-on i 300 ml tetrahydrofuran afkøles til -20°C, og opløsningen mættes med gasformig dihydrogensulfid.A solution of 16.3 g (0.1 mole) of 4-chloro-4-chloromethyl-oxetan-2-one in 300 ml of tetrahydrofuran is cooled to -20 ° C and the solution is saturated with gaseous dihydrogen sulfide.
Derefter tilsættes dråbevis under kraftig omrøring i 10 løbet af en time 20,4 g (0,2 mol) triethylamin. Reaktionsopløsningen henstår til opvarmning til stuetemperatur, hvorpå den efterrøres i en time, det udskilte salt fra-filtreres, og opløsningsmidlet afdampes på en rotationsfordamper til det halve rumfang. Til denne opløsning sæt-15 tes 19,1 g (0,1 mol) p-toluensulfonsyrechlorid, blandingen afkøles til 0°C, hvorpå der dråbevis tilsættes 10,2 g (0,1 mol) triethylamin. Det udskilte salt frafiltreres, og reaktionsopløsningen inddampes på en rotationsfordamper. Remanensen vaskes med 50 ml methanol. Man får 19,8 g 20 4-(p-toluensulfonyloxy)-thiophen-2 (5H)-on. som et tyndtlags- kromatografisk rent produkt med smp. 139-140°C. Dette svarer til et udbytte på 73,3%, beregnet på den anvendte oxetanon.Thereafter, 20.4 g (0.2 mole) of triethylamine are added dropwise with vigorous stirring for 10 hours. The reaction solution is allowed to warm to room temperature, then stirred for one hour, the separated salt is filtered off and the solvent is evaporated on a half-volume rotary evaporator. To this solution is added 19.1 g (0.1 mole) of p-toluenesulfonic acid chloride, the mixture is cooled to 0 ° C and 10.2 g (0.1 mole) of triethylamine are added dropwise. The separated salt is filtered off and the reaction solution is evaporated on a rotary evaporator. The residue is washed with 50 ml of methanol. 19.8 g of 4- (p-toluenesulfonyloxy) -thiophen-2 (5H) -one are obtained. as a thin layer chromatographically pure product with m.p. 139-140 ° C. This corresponds to a yield of 73.3%, based on the oxetanone used.
1H-NMR-spektrum (300 MHz, CDC13) 25 $ = 7,86 (d, J = 8,8 Hz, 2H) 7,43 (d, J = 8,8 Hz, 2H) 6,13 (t, J = 1,2 Hz, IH) 3.96 (d, J = 1,2 Hz, IH) 2,50 (s, 3H)1 H NMR Spectrum (300 MHz, CDCl 3) δ = 7.86 (d, J = 8.8 Hz, 2H) 7.43 (d, J = 8.8 Hz, 2H) 6.13 (t, J = 1.2 Hz, 1H) 3.96 (d, J = 1.2 Hz, 1H) 2.50 (s, 3H)
Eksempel 4Example 4
DK 162641BDK 162641B
77
Analogt med den ovenfor i eksempel 1 beskrevne fremgangsmåde, idet man dog i stedet for chlormyresyreethylester anvender 12,3 g (0,09 mol) chlormyresyrebutylester, frem-5 stilles 4-(n-butyloxycarbonyloxy)-thiophen-2(5H)-on i et udbytte på 75,7%, beregnet på anvendt oxetanon, i form af svagt brunlige krystaller med smp 28-29°C.By analogy to the procedure described in Example 1, however, using 12.3 g (0.09 mol) of chloromyric acid butyl ester instead of 4- (n-butyloxycarbonyloxy) -thiophene-2 (5H) -one, in a yield of 75.7%, based on oxetanone used, in the form of slightly brownish crystals, mp 28-29 ° C.
1H-NMR-spektrum (CDC13, 300 MHz) δ = 6,48 (t, J, c = 1,2 Hz, IH)1 H NMR spectrum (CDCl3, 300 MHz) δ = 6.48 (t, J, c = 1.2 Hz, 1H)
3 f D3 f D
10 4,30 (t, J = 6,9 Hz, 2H) 4,09 (d, J_ c = 1,2 Hz, 2H) 3/0 1,73 (m, 2H) 1,44 (m, 2H) 0,98 (t, J = 7,2 Hz, 3H) 15 Eksempel 54.30 (t, J = 6.9 Hz, 2H) 4.09 (d, J = c = 1.2 Hz, 2H) 3/0 1.73 (m, 2H) 1.44 (m, 2H) ) 0.98 (t, J = 7.2 Hz, 3H) Example 5
Analogt med den ovenfor i eksempel 1 beskrevne fremgangsmåde, idet der dog i stedet for chlormyresyreethylester anvendes 15,3 g (0,09 mol) chlormyresyrebenzylester, fremstilles 4-(benzyloxycarbonyloxy)-thiophen-2(5H)-on i et 20 udbytte på 74,1%, beregnet på anvendt oxetanon, i form af beigefarvede krystaller med smp. 82-83°C.Analogous to the procedure described in Example 1, although 15.3 g (0.09 mole) of chloroformic acid benzyl ester is used in place of chloroformic acid ethyl ester, 4- (benzyloxycarbonyloxy) -thiophen-2 (5H) -one is prepared in a yield of 74.1%, based on oxetanone used, in the form of beige crystals with m.p. 82-83 ° C.
1H-NMR-spektrum (CDC13, 300 MHz) δ = 7,41 (S, 5H) 6,49 (t, J3 5 = 1,2 Hz, IH) 25 5,28 (s, 2H) 4,07 (d, J0 c = 1,2 Hz, 2H) 3/01 H NMR Spectrum (CDCl3, 300 MHz) δ = 7.41 (S, 5H) 6.49 (t, J 3 = 1.2 Hz, 1H) 5.28 (s, 2H) 4.07 ( d, J0 c = 1.2 Hz, 2H) 3/0
Eksempel 6Example 6
DK 162641 BDK 162641 B
8 3/8 g (0/02 mol) 4-(ethoxycarbonyloxy)-thiophen-2(5H)-on opløses i 25 ml tetrahydrofuran, og opløsningen afkøles til -10°C. Til denne opløsning sættes en opløsning af 5 2,9 g (0,04 mol) diethylamin i 35 ml tetrahydrofuran.Dissolve 3/8 g (0/02 mol) of 4- (ethoxycarbonyloxy) -thiophen-2 (5H) -one in 25 ml of tetrahydrofuran and cool the solution to -10 ° C. To this solution is added a solution of 2.9 g (0.04 mole) of diethylamine in 35 ml of tetrahydrofuran.
Det udskilte faste stof frasuges (diethylammoniumsalt af thiotetronsyre) og optages i 20 ml vand. Blandingen syrnes under omrøring med koncentreret saltsyre til pH-værdien 1-2. Den udfældede thiotetronsyre ekstraheres 10 med 100 ml ethylacetat. Den organiske fase tørres med Na2S0^, hvorefter opløsningsmidlet afdampes på en rotationsf ordamper. Remanensen tørres i højvakuum. Man får 2,0 g thiotetronsyre som et næsten hvidt, mikrokrystal-linsk produkt med smp. 120-122°C med en renhed på 96,9% 15 (NaOH-titrering). Dette svarer til 1,9 g 100%'s rent produkt eller et udbytte på 83,6%, beregnet på den anvendte 4- (ethoxycarbonyloxy) -thiophen-2 (5H) -on.The separated solid is aspirated (diethylammonium salt of thiotetronic acid) and taken up in 20 ml of water. The mixture is acidified with stirring with concentrated hydrochloric acid to pH 1-2. The precipitated thiotetronic acid is extracted with 100 ml of ethyl acetate. The organic phase is dried over Na 2 SO 4 and the solvent is evaporated on a rotary evaporator. The residue is dried in high vacuum. 2.0 g of thiotetronic acid is obtained as an almost white microcrystalline lens product, m.p. 120-122 ° C with a purity of 96.9% (NaOH titration). This corresponds to 1.9 g of 100% pure product or a yield of 83.6%, based on the 4- (ethoxycarbonyloxy) -thiophen-2 (5H) -one used.
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH215885 | 1985-05-21 | ||
CH2158/85A CH668071A5 (en) | 1985-05-21 | 1985-05-21 | THIOPHENONE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF. |
Publications (4)
Publication Number | Publication Date |
---|---|
DK233186D0 DK233186D0 (en) | 1986-05-20 |
DK233186A DK233186A (en) | 1986-11-22 |
DK162641B true DK162641B (en) | 1991-11-25 |
DK162641C DK162641C (en) | 1992-05-04 |
Family
ID=4227236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK233186A DK162641C (en) | 1985-05-21 | 1986-05-20 | 4-SUBSTITUTED THIOPHEN-2 (5H) -ON DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0203495B1 (en) |
JP (1) | JPH0645616B2 (en) |
AT (1) | ATE40998T1 (en) |
CA (1) | CA1266274A (en) |
CH (1) | CH668071A5 (en) |
DE (1) | DE3662195D1 (en) |
DK (1) | DK162641C (en) |
IE (1) | IE58781B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0485613B1 (en) * | 1990-05-25 | 1995-12-06 | Mitsubishi Chemical Corporation | Process for para-methylolating phenolic compound |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0130025B1 (en) * | 1983-06-21 | 1987-07-08 | Pfizer Inc. | 2-alkylthiopenem derivatives |
-
1985
- 1985-05-21 CH CH2158/85A patent/CH668071A5/en not_active IP Right Cessation
-
1986
- 1986-04-28 IE IE111586A patent/IE58781B1/en not_active IP Right Cessation
- 1986-05-05 CA CA000508417A patent/CA1266274A/en not_active Expired - Fee Related
- 1986-05-16 JP JP61112434A patent/JPH0645616B2/en not_active Expired - Lifetime
- 1986-05-20 DK DK233186A patent/DK162641C/en not_active IP Right Cessation
- 1986-05-20 AT AT86106821T patent/ATE40998T1/en not_active IP Right Cessation
- 1986-05-20 DE DE8686106821T patent/DE3662195D1/en not_active Expired
- 1986-05-20 EP EP86106821A patent/EP0203495B1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DK233186A (en) | 1986-11-22 |
DE3662195D1 (en) | 1989-04-06 |
EP0203495B1 (en) | 1989-03-01 |
IE58781B1 (en) | 1993-11-17 |
JPH0645616B2 (en) | 1994-06-15 |
JPS61271285A (en) | 1986-12-01 |
EP0203495A1 (en) | 1986-12-03 |
CA1266274A (en) | 1990-02-27 |
DK233186D0 (en) | 1986-05-20 |
CH668071A5 (en) | 1988-11-30 |
ATE40998T1 (en) | 1989-03-15 |
IE861115L (en) | 1986-11-21 |
DK162641C (en) | 1992-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10358423B2 (en) | Processes for the preparation of 4-alkoxy-3-(acyl or alkyl)oxypicolinamdes | |
US20180186753A1 (en) | Processes for the preparation of pesticidal compounds | |
US20040049053A1 (en) | Process for the prepartion of 1,2-benzisoxazole-3-acetic acid | |
NO166712B (en) | PROCEDURE FOR THE PREPARATION OF PYRROLIDO DERIVATIVES. | |
DK162641B (en) | 4-SUBSTITUTED THIOPHEN-2 (5H) -ON DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF | |
Shimadzu et al. | Studies on furan derivatives. XIV. Nucleophilic substitution of methyl 5‐nitro‐2‐furancarboxylate and 5‐Nitrofuran‐2‐nitrile | |
US3435047A (en) | Process for preparing 3-aminoisoxazole derivatives | |
Rassadin et al. | Synthesis of sultams by cycloalkylation of (alkoxycarbonylmethane) sulfonanilides | |
KR940008923B1 (en) | Amino acetonitrile derivatives | |
KR890001241B1 (en) | Process for preparing 4-acetyl isoquinolinone | |
US7291742B2 (en) | Process for the preparation of benzo [d] isoxazol-3-yl-methanesulfonic acid and the intermediates thereof | |
DK162642B (en) | PROCEDURE FOR THE PREPARATION OF THIOTETRONIC ACID | |
KR100371590B1 (en) | Process for the preparation of 2-chloropyridine | |
JP4075357B2 (en) | 4,5-disubstituted-1,2,3-triazole and process for producing the same | |
KR920003690B1 (en) | Process for preparation of quinoline derivatives | |
RU1795969C (en) | Method of benzoylurea derivatives synthesis | |
NO169587B (en) | PROCEDURE FOR THE PREPARATION OF 4-ALCOXY-2 (5H) -TIOPHENONES | |
KR101086039B1 (en) | Novel process for preparing 3,4-dihydro-pyrano[3,4-c]pyridin-1-one derivatives | |
KR20060125907A (en) | One-pot process for producing 1,2-benzisoxazole-3-methanesulfonamide | |
JPH0569831B2 (en) | ||
SE430501B (en) | 5-SUBSTITUTED N - ((1-CYCLOALKYL-ALKYL-PYRROLIDIN-2-YL) -METHYL) -2-METOXY-BENZ-AMIDES WITH THERAPEUTICAL PROPERTIES AND THEIR PREPARATION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment | ||
PBP | Patent lapsed |